MedTrace Logo

Weight Loss Maintenance of a New Bioactive Compound (Metobes-Long)

NCT00302276 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2009-01-21

No results posted yet for this study

Summary

The objective of the present study was to investigate the acute and sub-chronic effect of a supplement containing green tea extract, capsaisin, caffeine, tyrosine and calcium or placebo taken t.i.d on thermogenesis, body fat loss, and fecal fat excretion. Furthermore, if a 8-week supplementation could prevent weight-regain after initial 4-week weight loss.

Conditions

Interventions

DRUG

Metobes-compound

Sponsors & Collaborators

  • University of Copenhagen

    lead OTHER

Principal Investigators

  • Jens Kondrup, Prof · Department of Human Nutrition, The Royal Veterinary and Agricultural University, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-01-31
Completion
2004-07-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00302276 on ClinicalTrials.gov